|
Oct 12
|
Is Alkermes (ALKS) The Most Undervalued Quality Stock To Buy According To Analysts?
|
|
Oct 9
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|
|
Oct 2
|
Alkermes (NASDAQ:ALKS) shareholder returns have been favorable, earning 62% in 5 years
|
|
Sep 25
|
Alkermes to Host Investor Event to Review Orexin Portfolio Strategy
|
|
Sep 23
|
Alkermes to Present Positive Clinical Data From Phase 1b Study of ALKS 2680 in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia at Sleep Europe 2024
|
|
Sep 13
|
Alkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards® Program
|
|
Aug 30
|
Why Is Qiagen (QGEN) Down 0.3% Since Last Earnings Report?
|
|
Aug 29
|
Incyte (INCY) Up 0.9% Since Last Earnings Report: Can It Continue?
|
|
Aug 28
|
Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
|
|
Jul 31
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Jul 30
|
Why Alkermes (ALKS) is a Top Value Stock for the Long-Term
|
|
Jul 25
|
Alkermes' (ALKS) Q2 Earnings Miss Estimates, Revenues Beat
|
|
Jul 24
|
Alkermes (ALKS) Reports Q2 Earnings: What Key Metrics Have to Say
|
|
Jul 24
|
Alkermes (ALKS) Lags Q2 Earnings Estimates
|
|
Jul 24
|
Is Alkermes plc's (NASDAQ:ALKS) Latest Stock Performance Being Led By Its Strong Fundamentals?
|
|
Jul 24
|
Alkermes plc Reports Second Quarter 2024 Financial Results
|
|
Jun 24
|
Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar?
|
|
Jun 3
|
Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024
|
|
May 31
|
Why Is Alkermes (ALKS) Down 2.7% Since Last Earnings Report?
|
|
May 29
|
Alkermes to Participate in Two Upcoming Investor Conferences
|